A study titled "Detection of CJC-1295 in Equine Plasma by ELISA" was published on October 14, 2026. The publication appeared in the journal Drug Testing and Analysis. CJC-1295 remains classified as an unapproved research compound. This entry reflects a new addition to the scientific literature concerning detection methods for the compound in equine plasma samples. No findings, results, or conclusions from the study were provided alongside this publication record. As with all research publications, details on methodology, outcomes, and implications would be found within the full text of the article itself. Readers interested in the broader context of CJC-1295, including its regulatory status and general background, can refer to the compound overview for additional information.
New Publication: CJC-1295 Detection in Equine Plasma by ELISA
See the full cjc-1295 overview
Source: https://pubmed.ncbi.nlm.nih.gov/42876013/